How to Prepare a Labetalol Drip
Prepare labetalol continuous infusion by adding 200 mg (either two 20-mL vials or one 40-mL vial) to 160 mL of compatible IV fluid to create a 200 mL solution containing 1 mg/mL, then infuse at 2 mL/min to deliver 2 mg/min. 1
Standard Preparation Methods
The FDA-approved drug label provides two specific preparation protocols 1:
Method 1 (1 mg/mL concentration - Preferred):
- Add 40 mL of labetalol injection (200 mg total) to 160 mL of IV fluid 1
- Final volume: 200 mL containing 200 mg labetalol (1 mg/mL) 1
- Infusion rate: 2 mL/min delivers 2 mg/min 1
Method 2 (Alternative concentration):
- Add 40 mL of labetalol injection (200 mg total) to 250 mL of IV fluid 1
- Final volume: 290 mL containing approximately 2 mg/3 mL 1
- Infusion rate: 3 mL/min delivers approximately 2 mg/min 1
Compatible IV Fluids
Labetalol is stable for 24 hours (refrigerated or at room temperature) when mixed with 1:
- 0.9% Sodium Chloride (Normal Saline) 1
- 5% Dextrose in Water (D5W) 1
- Lactated Ringer's 1
- Ringer's Injection 1
- 5% Dextrose and 0.2%, 0.33%, 0.45%, or 0.9% Sodium Chloride combinations 1
- 2.5% Dextrose and 0.45% Sodium Chloride 1
Critical Incompatibility:
Do NOT mix labetalol with 5% Sodium Bicarbonate—it is incompatible 1
Titration Protocol
Starting the Infusion:
- Begin at 2 mg/min and adjust according to blood pressure response 1
- Use a controlled administration mechanism (graduated burette or infusion pump) for precise delivery 1
- Continue infusion until satisfactory response is achieved, then transition to oral labetalol 1
Effective Dose Range:
Critical Monitoring Requirements
Patient Positioning:
Keep patients supine during the entire period of IV administration 1
- Expect substantial fall in blood pressure when standing 1
- Establish patient's ability to tolerate upright position before allowing ambulation 1
Blood Pressure Monitoring:
- Monitor continuously during infusion 1
- Avoid rapid or excessive falls in systolic or diastolic pressure 1
- In excessive systolic hypertension, use systolic pressure decrease as an indicator of effectiveness in addition to diastolic response 1
Pharmacokinetic Considerations
- Half-life: 5-8 hours, meaning steady-state levels will not be reached during usual infusion periods 1
- Onset of action occurs within minutes of starting infusion 2
- The drug undergoes significant hepatic first-pass metabolism (approximately 85% removed in single liver passage) 3
Common Pitfalls to Avoid
- Never use 5% Sodium Bicarbonate as the diluent—this is the only incompatible solution 1
- Do not allow patients to ambulate without first testing upright tolerance—postural hypotension is the most troublesome side effect 1, 4
- Avoid in patients with heart block, bradycardia, decompensated heart failure, or reactive airways disease 5
- Always inspect the solution visually for particulate matter and discoloration before administration 1
Transition to Oral Therapy
Once supine diastolic blood pressure begins to rise 1: